宜明昂科生物医药技术（上海）股份有限公司（01541）于2026年2月5日发布2026年1月股份变动月报表，披露截至1月31日的股本情况。公司注册股本合计人民币431,507,695元，分为420,477,305股已在香港联交所上市的H股及11,030,390股非上市股份，各类股份数量均未出现新增或减少。
根据月报表，1月份内公司并无股份发行、购回或注销活动，也无期权、可换股票据或其他股权激励计划的变动。截至1月底，公司在港上市H股总数为420,477,305股，无库存股，非上市股份为11,030,390股，股本结构保持稳定。公司同时声明遵守香港联交所《上市规则》及相关法律规定。公告由该公司执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.